124 related articles for article (PubMed ID: 35551467)
1. Preoperative CA19-9 is a prognostic factor in pT3N0 gastric cancer patients undergoing curative resection.
Maruyama T; Akashi Y; Hakoda H; Sako A; Ueda K; Kato S; Azuma K; Kaneko Y; Ikeguchi A; Nagai S; Oda T
Langenbecks Arch Surg; 2022 Sep; 407(6):2273-2279. PubMed ID: 35551467
[TBL] [Abstract][Full Text] [Related]
2. CA19‑9 is a significant prognostic factor in stage III gastric cancer patients undergoing radical gastrectomy.
Ma X; Zhou X; Guo J; Feng X; Zhao M; Zhang P; Zhang C; Gong S; Wu N; Zhang Y; Zhang X; Ren Z; Zhang P
BMC Surg; 2024 Jan; 24(1):31. PubMed ID: 38263014
[TBL] [Abstract][Full Text] [Related]
3. CA19-9 is a significant prognostic marker of patients with stage III gastric cancer.
Kambara Y; Miyake H; Nagai H; Yoshioka Y; Shibata K; Asai S; Yuasa N
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1918-1924. PubMed ID: 32814681
[TBL] [Abstract][Full Text] [Related]
4. Span-1 and CA19-9 as Predictors of Early Recurrence and Lymph Node Metastasis for Patients with Invasive Pancreatic Cancer after Pancreatectomy.
Shimizu T; Asakuma M; Tomioka A; Inoue Y; Hirokawa F; Hayashi M; Uchiyama K
Am Surg; 2018 Jan; 84(1):109-113. PubMed ID: 29428036
[TBL] [Abstract][Full Text] [Related]
5. Post-adjuvant chemotherapy CA19-9 levels predict prognosis in patients with pancreatic ductal adenocarcinoma: A retrospective cohort study.
Imaoka H; Shimizu Y; Senda Y; Natsume S; Mizuno N; Hara K; Hijioka S; Hieda N; Tajika M; Tanaka T; Ishihara M; Niwa Y; Yamao K
Pancreatology; 2016; 16(4):658-64. PubMed ID: 27178104
[TBL] [Abstract][Full Text] [Related]
6. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
7. The predictive factors of gastric cancer recurrence after the completion of adjuvant chemotherapy in advanced gastric cancer.
Kim YJ; Chung WC; Youn GJ; Jun KH; Chin HM
Rev Esp Enferm Dig; 2019 Jul; 111(7):537-542. PubMed ID: 31215209
[TBL] [Abstract][Full Text] [Related]
8. Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.
Nishibeppu K; Komatsu S; Ichikawa D; Imamura T; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
BMC Cancer; 2018 Jan; 18(1):108. PubMed ID: 29382310
[TBL] [Abstract][Full Text] [Related]
9. [Preoperative C-reactive protein predicts recurrence after curative resection in advanced gastric cancer patients receiving postoperative adjuvant chemotherapy using S-1].
Shimizu T; Ishizuka M; Sakuraoka Y; Shiraki T; Abe A; Mori S; Iso Y; Takagi K; Aoki T; Kubota K
Nihon Shokakibyo Gakkai Zasshi; 2020; 117(2):150-156. PubMed ID: 32037360
[TBL] [Abstract][Full Text] [Related]
10. Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer.
Liu X; Zhang D; Lin E; Chen Y; Li W; Chen Y; Sun X; Zhou Z
BMC Cancer; 2018 Jun; 18(1):699. PubMed ID: 29954375
[TBL] [Abstract][Full Text] [Related]
11. Oncological outcomes in patients with pT1N0-3 or pT2-3N0 gastric cancer after curative resection without adjuvant chemotherapy.
Yagi S; Nunobe S; Makuuchi R; Ida S; Kumagai K; Ohashi M; Sano T
Langenbecks Arch Surg; 2021 Mar; 406(2):419-426. PubMed ID: 33515064
[TBL] [Abstract][Full Text] [Related]
12. Comparison of CEA and CA19-9 as a predictive factor for recurrence after curative gastrectomy in gastric cancer.
Shibata C; Nakano T; Yasumoto A; Mitamura A; Sawada K; Ogawa H; Miura T; Ise I; Takami K; Yamamoto K; Katayose Y
BMC Surg; 2022 Jun; 22(1):213. PubMed ID: 35655198
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment Serum Carbohydrate Antigen 19-9 Concentration Is a Predictor of Survival of Patients Who Have Undergone Curative Resection of Stage IV Rectal Cancer.
Miki H; Akiyoshi T; Ogura A; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Noma H; Saiura A; Fukunaga Y; Ueno M
Dig Surg; 2018; 35(5):389-396. PubMed ID: 28858867
[TBL] [Abstract][Full Text] [Related]
14. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
15. The association of the lymph node ratio and serum carbohydrate antigen 19-9 with early recurrence after curative gastrectomy for gastric cancer.
Sawayama H; Iwatsuki M; Kuroda D; Toihata T; Uchihara T; Koga Y; Yagi T; Kiyozumi Y; Eto T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Baba H
Surg Today; 2018 Nov; 48(11):994-1003. PubMed ID: 29926189
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
Scand J Gastroenterol; 2019 Jun; 54(6):780-786. PubMed ID: 31180790
[No Abstract] [Full Text] [Related]
17. Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
Lin JX; Wang W; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Zhou ZW; Li P
Ann Surg Oncol; 2018 Sep; 25(9):2703-2712. PubMed ID: 29971670
[TBL] [Abstract][Full Text] [Related]
18. Nomograms predicting prognosis of patients with pathological stages T1N2-3 and T3N0 gastric cancer.
Wang YF; Yin X; Fang TY; Wang YM; Zhang DX; Zhang Y; Wang XB; Wang H; Xue YW
World J Gastrointest Surg; 2022 Feb; 14(2):143-160. PubMed ID: 35317546
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of preoperative CA19-9 and lymph node metastasis in intrahepatic cholangiocarcinoma.
Asaoka T; Kobayashi S; Hanaki T; Iwagami Y; Tomimaru Y; Akita H; Noda T; Gotoh K; Takeda Y; Tanemura M; Doki Y; Eguchi H
Surg Today; 2020 Oct; 50(10):1176-1186. PubMed ID: 32221659
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the prognostic factors in patients with pT3N0 or pT1N2-3 gastric cancer: a single institutional retrospective cohort study.
Terada M; Kinoshita T; Kaito A; Sugita S; Watanabe M; Hayashi R
Surg Today; 2018 Mar; 48(3):325-332. PubMed ID: 28993997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
